208 related articles for article (PubMed ID: 32222055)
1. How to choose a point-of-care testing for troponin.
Lin YH; Zhang Y; Liu YT; Cui K; Kang JS; Zhou Z
J Clin Lab Anal; 2020 Jul; 34(7):e23263. PubMed ID: 32222055
[TBL] [Abstract][Full Text] [Related]
2. Analytical Concordance of Diverse Point-of-Care and Central Laboratory Troponin I Assays.
Tsui AKY; Lyon ME; van Diepen S; Goudreau BL; Thomas D; Higgins T; Raizman JE; Füzéry AK; Rodriguez-Capote K; Estey M; Cembrowski G
J Appl Lab Med; 2019 Mar; 3(5):764-774. PubMed ID: 31639752
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?
Bargnoux AS; Kuster N; Patrier L; Dupuy AM; Tachon G; Maurice F; Badaoui B; Chalabi L; Badiou S; Deleuze S; Leray-Moragues H; Morena M; Canaud B; Cristol JP
Clin Chem Lab Med; 2016 Apr; 54(4):673-82. PubMed ID: 26457775
[TBL] [Abstract][Full Text] [Related]
4. Rule-out of non-ST elevation myocardial infarction by five point of care cardiac troponin assays according to the 0 h/3 h algorithm of the European Society of Cardiology.
Suh D; Keller DI; Hof D; von Eckardstein A; Gawinecka J
Clin Chem Lab Med; 2018 Mar; 56(4):649-657. PubMed ID: 29257750
[TBL] [Abstract][Full Text] [Related]
5. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population.
Apple FS; Ler R; Murakami MM
Clin Chem; 2012 Nov; 58(11):1574-81. PubMed ID: 22983113
[TBL] [Abstract][Full Text] [Related]
6. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays.
Mingels A; Jacobs L; Michielsen E; Swaanenburg J; Wodzig W; van Dieijen-Visser M
Clin Chem; 2009 Jan; 55(1):101-8. PubMed ID: 18988757
[TBL] [Abstract][Full Text] [Related]
7. The 99th percentile and imprecision of point-of-care cardiac troponin I in comparison to central laboratory tests in a large reference population.
Greiser A; Winter T; Mahfoud H; Kallner A; Ittermann T; Masuch A; Lubenow N; Kohlmann T; Greinacher A; Nauck M; Petersmann A
Clin Biochem; 2017 Dec; 50(18):1198-1202. PubMed ID: 28803961
[TBL] [Abstract][Full Text] [Related]
8. Addition of copeptin improves diagnostic performance of point-of-care testing (POCT) for cardiac troponin T in early rule-out of myocardial infarction - A pilot study.
Vafaie M; Biener M; Mueller M; Abu Sharar H; Hartmann O; Hertel S; Katus HA; Giannitsis E
Int J Cardiol; 2015 Nov; 198():26-30. PubMed ID: 26149334
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy between Cardiac Troponin Assays Due to Endogenous Antibodies.
Lam L; Aspin L; Heron RC; Ha L; Kyle C
Clin Chem; 2020 Mar; 66(3):445-454. PubMed ID: 32031592
[TBL] [Abstract][Full Text] [Related]
10. Peri-operative troponin monitoring using a prototype high-sensitivity cardiac troponin I (hs-cTnI) assay: comparisons with hs-cTnT and contemporary cTnI assays.
Lee GR; Jhanji S; Tarrant H; James S; Pearse RM; Fitzgibbon M
Ann Clin Biochem; 2014 Mar; 51(Pt 2):258-68. PubMed ID: 24048718
[TBL] [Abstract][Full Text] [Related]
11. 5th generation cardiac troponin I and T assays in clinical routine - A head-to-head comparison with data from the Linz troponin (LITROP) study.
Mueller T; Egger M; Peer E; Dieplinger B
Clin Chim Acta; 2018 Oct; 485():195-204. PubMed ID: 29958891
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of the Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid with a point-of-care cardiac troponin assay.
Alghamdi A; Reynard C; Morris N; Moss P; Jarman H; Hardy E; Harris T; Horner D; Parris R; Body R
Emerg Med J; 2020 Apr; 37(4):223-228. PubMed ID: 32047076
[TBL] [Abstract][Full Text] [Related]
13. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
[TBL] [Abstract][Full Text] [Related]
14. Clinical performance of 0/1 h cardiac troponin algorithm for diagnosing non-STEMI in an emergency setting.
Gou Q; Liang L; Liu D; Jia J; Dong M; Chen H; Shou X
Am J Emerg Med; 2023 Sep; 71():139-143. PubMed ID: 37392513
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of clinical decision limits for cardiac troponin T and I.
Kimenai DM; Henry RM; van der Kallen CJ; Dagnelie PC; Schram MT; Stehouwer CD; van Suijlen JD; Niens M; Bekers O; Sep SJ; Schaper NC; van Dieijen-Visser MP; Meex SJ
Heart; 2016 Apr; 102(8):610-6. PubMed ID: 26794233
[TBL] [Abstract][Full Text] [Related]
16. Frequency histograms of three high-sensitivity cardiac troponin assays in a reference population.
Cho H; Kim H; Lee J; Kim SY; Lee HK; Kwon HJ; Kim Y
J Clin Lab Anal; 2022 Jun; 36(6):e24432. PubMed ID: 35441734
[TBL] [Abstract][Full Text] [Related]
17. High-sensitivity cardiac troponin T is superior to troponin I in the prediction of mortality in patients without acute coronary syndrome.
Árnadóttir Á; Vestergaard KR; Pallisgaard J; Sölétormos G; Steffensen R; Goetze JP; Iversen K
Int J Cardiol; 2018 May; 259():186-191. PubMed ID: 29477263
[TBL] [Abstract][Full Text] [Related]
18. Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors.
Mueller T; Egger M; Leitner I; Gabriel C; Haltmayer M; Dieplinger B
Clin Chim Acta; 2016 May; 456():19-23. PubMed ID: 26920637
[TBL] [Abstract][Full Text] [Related]
19. Detectable High-Sensitivity Cardiac Troponin within the Population Reference Interval Conveys High 5-Year Cardiovascular Risk: An Observational Study.
Than MP; Aldous SJ; Troughton RW; Pemberton CJ; Richards AM; Frampton CMA; Florkowski CM; George PM; Bailey S; Young JM; Cullen L; Greenslade JH; Parsonage WA; Everett BM; Peacock WF; Jaffe AS; Pickering JW
Clin Chem; 2018 Jul; 64(7):1044-1053. PubMed ID: 29760219
[TBL] [Abstract][Full Text] [Related]
20. Discordance with 3 Cardiac Troponin I and T Assays: Implications for the 99th Percentile Cutoff.
Ungerer JP; Tate JR; Pretorius CJ
Clin Chem; 2016 Aug; 62(8):1106-14. PubMed ID: 27335076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
